Page last updated: 2024-08-21

8-aminoquinoline and tafenoquine

8-aminoquinoline has been researched along with tafenoquine in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's6 (46.15)18.2507
2000's0 (0.00)29.6817
2010's4 (30.77)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Bartlett, MS; Berman, JD; Dean, RA; Ellis, WY; Milhous, WK; Queener, SF; Smith, JW1
Baskin, SI; Fricke, RF; Scharf, BA1
Baskin, SI; Clark, JH; Kirby, SD; Steinhaus, RK1
Anders, JC; Chung, H; Theoharides, AD1
Bartlett, MS; Goheen, MP; Queener, SF; Shaw, MM; Smith, JW1
Eberhard, ML; Ellis, WL; Marley, SE; McGreevy, PB; Ruebush, TK; Steurer, FJ1
Brueckner, RP; Coster, T; Schuster, BG; Shmuklarsky, M; Wesche, DL1
Croft, SL; Gamarro, F; Yardley, V1
Baresel, PC; Campo, B; Magill, AJ; Ohrt, C; Rochford, R; Sampath, A; Tekwani, BL; Walker, LA1
Burrows, JN; Campo, B; Vandal, O; Wesche, DL1
Kaewpruk, N; Mungthin, M; Sitthichot, N; Suwandittakul, N; Tan-ariya, P; Ward, SA1
Calvaresi, EC; Genzen, JR1
Lampejo, T1

Reviews

1 review(s) available for 8-aminoquinoline and tafenoquine

ArticleYear
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
    Pathogens and global health, 2015, Volume: 109, Issue:3

    Topics: Aminoquinolines; Antimalarials; Chemical and Drug Induced Liver Injury; Disease Eradication; Drug Discovery; Humans; Liver; Malaria, Vivax; Plasmodium vivax; Recurrence; Sporozoites

2015

Trials

1 trial(s) available for 8-aminoquinoline and tafenoquine

ArticleYear
Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5

    Topics: Adult; Aminoquinolines; Animals; Antimalarials; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum

1998

Other Studies

11 other study(ies) available for 8-aminoquinoline and tafenoquine

ArticleYear
Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
    The Journal of infectious diseases, 1992, Volume: 165, Issue:4

    Topics: Aminoquinolines; Animals; Clindamycin; Disease Models, Animal; Drug Administration Schedule; Female; Pneumonia, Pneumocystis; Primaquine; Rats; Rats, Inbred Strains; Specific Pathogen-Free Organisms; Trimethoprim, Sulfamethoxazole Drug Combination

1992
Comparison of methemoglobin formers in protection against the toxic effects of cyanide.
    General pharmacology, 1992, Volume: 23, Issue:1

    Topics: Aminoquinolines; Aniline Compounds; Animals; Dose-Response Relationship, Drug; Hemoglobins; Ketones; Lethal Dose 50; Male; Methemoglobin; Mice; Mice, Inbred ICR; Motor Activity; Oxidation-Reduction; Primaquine; Propiophenones; Sodium Cyanide

1992
Formation of methemoglobin and metmyoglobin using 8-aminoquinoline derivatives or sodium nitrite and subsequent reaction with cyanide.
    Journal of applied toxicology : JAT, 1990, Volume: 10, Issue:5

    Topics: Aminoquinolines; Chemical Phenomena; Chemistry, Physical; Cyanides; Humans; Indicators and Reagents; Kinetics; Methemoglobin; Metmyoglobin; Oxidation-Reduction; Primaquine; Protein Binding; Sodium Nitrite

1990
Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1988, Volume: 10, Issue:2

    Topics: Aminoquinolines; Animals; Antimalarials; Body Weight; Dogs; Hemoglobins; Male; Methemoglobinemia

1988
Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii.
    International journal of experimental pathology, 1993, Volume: 74, Issue:4

    Topics: Aminoquinolines; Humans; Microscopy, Electron; Pneumocystis; Primaquine

1993
Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1

    Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Babesiosis; Cricetinae; Drug Evaluation, Preclinical; Mesocricetus; Pyrroles; Quinazolines

1997
Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Female; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Primaquine; Trypanosoma cruzi

2010
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Oct-22, Volume: 110, Issue:43

    Topics: Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Doxycycline; Drug Evaluation, Preclinical; Erythrocyte Count; Erythrocyte Transfusion; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Mefloquine; Mice; Mice, Inbred NOD; Mice, SCID; Primaquine; Pyrimethamine; Reproducibility of Results; Sensitivity and Specificity; Transplantation, Heterologous

2013
PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
    The Southeast Asian journal of tropical medicine and public health, 2016, Volume: 47, Issue:3

    Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Primaquine; Thailand

2016
Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity.
    American journal of clinical pathology, 2020, 07-07, Volume: 154, Issue:2

    Topics: Adolescent; Adult; Aged; Aminoquinolines; Antimalarials; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase; Hematologic Tests; Humans; Infant; Malaria; Male; Middle Aged; Reference Values; Retrospective Studies; Young Adult

2020
Is low-dose tafenoquine combined with dihydroartemisinin-piperaquine a potential risk factor for Plasmodium vivax resistance to 8-aminoquinolines?
    The Lancet. Microbe, 2022, Volume: 3, Issue:7

    Topics: Aminoquinolines; Artemisinins; Piperazines; Plasmodium vivax; Quinolines; Risk Factors

2022